Maryam Fouladi, MD
Nationwide Children's Hospital
10
6
0
N/A
0
7
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
+15 more interventions
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (10)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Nicholas G Gottardo, MB FRACP PhD
Perth Children's Hospital
Shared therapeutic areas:
Worked with same sponsors:
Santosh Valvi, FRACP, MSc
Perth Children's Hospital
Shared therapeutic areas:
Worked with same sponsors:
Michael J Fisher, MD
Children's Hospital of Philadelphia
Shared therapeutic areas:
Worked with same sponsors:
Margot Lazow, MD
Nationwide Children's Hospital
Shared therapeutic areas:
Worked with same sponsors:
Hamza Gorsi, MD
Children's Hospital of Michigan
Shared therapeutic areas:
Worked with same sponsors:
Holly Lindsay, MD
Children's Hospital Colorado
Shared therapeutic areas:
Worked with same sponsors:
Todd C Hankinson, MD
Children's Hospital Colorado
Shared therapeutic areas:
Worked with same sponsors:
Daniel Landi, MD
Duke Cancer Center
Shared therapeutic areas:
Worked with same sponsors:
Eric M Thompson, MD
Washington University - St. Louis Children's Hospital
Shared therapeutic areas:
Worked with same sponsors:
Patricia Baxter, MD
Baylor College of Medicine
Shared therapeutic areas:
Worked with same sponsors:
Publications (0)
No publications found for this investigator.
Clinical Trials (10)
Showing 10 of 10 trials
Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
Study of Olutasidenib and Temozolomide in HGG
Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
Targeted Pediatric High-Grade Glioma Therapy
PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
MEKTOVI® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma
ACTEMRA® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma
A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion
A Phase 1b Study of PTC596 in Children With Newly Diagnosed Diffuse Intrinsic Pontine Glioma and High Grade Glioma
Comparison of Neurocognitive Outcome in Two Standard Regimen for Treatment of Low-risk Medulloblastoma
All 10 trials loaded